Literature DB >> 25055800

Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis.

L K Wei1, S Menon2, L R Griffiths2, S H Gan3.   

Abstract

Irregular atrial pressure, defective folate and cholesterol metabolism contribute to the pathogenesis of hypertension. However, little is known about the combined roles of the methylenetetrahydrofolate reductase (MTHFR), apolipoprotein-E (ApoE) and angiotensin-converting enzyme (ACE) genes, which are involved in metabolism and homeostasis. The objective of this study is to investigate the association of the MTHFR 677 C>T and 1298A>C, ACE insertion-deletion (I/D) and ApoE genetic polymorphisms with hypertension and to further explore the epistasis interactions that are involved in these mechanisms. A total of 594 subjects, including 348 normotensive and 246 hypertensive ischemic stroke subjects were recruited. The MTHFR 677 C>T and 1298A>C, ACE I/D and ApoEpolymorphisms were genotyped and the epistasis interaction were analyzed. The MTHFR 677 C>T and ApoE polymorphisms demonstrated significant associations with susceptibility to hypertension in multiple logistic regression models, multifactor dimensionality reduction and a classification and regression tree. In addition, the logistic regression model demonstrated that significant interactions between the ApoE E3E3, E2E4, E2E2 and MTHFR 677 C>T polymorphisms existed. In conclusion, the results of this epistasis study indicated significant association between the ApoE and MTHFR polymorphisms and hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25055800     DOI: 10.1038/jhh.2014.53

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  32 in total

1.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Authors:  Maple M Fung; Rany M Salem; Michael S Lipkowitz; Vibha Bhatnagar; Braj Pandey; Nicholas J Schork; Daniel T O'Connor
Journal:  Nephrol Dial Transplant       Date:  2011-05-25       Impact factor: 5.992

2.  Combined effect of Factor V Leiden, MTHFR, and angiotensin-converting enzyme (insertion/deletion) gene mutations in hypertensive adult individuals: a population-based study from Sivas and Canakkale, Turkey.

Authors:  Yeltekin Demirel; Sezai Dogan; Ahmet Uludag; Coskun Silan; Sinem Atik; Fatma Silan; Ozturk Ozdemir
Journal:  Genet Test Mol Biomarkers       Date:  2011-06-23

3.  ACE gene and physical activity, blood pressure, and hypertension: a population study in Finland.

Authors:  Ricardo M Fuentes; Markus Perola; Aulikki Nissinen; Jaakko Tuomilehto
Journal:  J Appl Physiol (1985)       Date:  2002-06

4.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

5.  Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2.

Authors:  Min Shi; Diana Caprau; Paul Romitti; Kaare Christensen; Jeffrey C Murray
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-08

6.  Association of MTHFR C677T and A1298C gene polymorphisms with hypertension.

Authors:  Abdullah Alghasham; Ahmad A Settin; Ahmad Ali; Moataz Dowaidar; Hisham Ismail
Journal:  Int J Health Sci (Qassim)       Date:  2012-01

7.  Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.

Authors:  Maja Krajinovic; Stephanie Lamothe; Damian Labuda; Emilie Lemieux-Blanchard; Yves Theoret; Albert Moghrabi; Daniel Sinnett
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

8.  A novel multiplex PCR-RFLP method for simultaneous detection of the MTHFR 677 C > T, eNOS +894 G > T and - eNOS -786 T > C variants among Malaysian Malays.

Authors:  Keat Wei Loo; Lyn Robyn Griffiths; Siew Hua Gan
Journal:  BMC Med Genet       Date:  2012-05-17       Impact factor: 2.103

9.  Population genetic structure of peninsular Malaysia Malay sub-ethnic groups.

Authors:  Wan Isa Hatin; Ab Rajab Nur-Shafawati; Mohd-Khairi Zahri; Shuhua Xu; Li Jin; Soon-Guan Tan; Mohammed Rizman-Idid; Bin Alwi Zilfalil
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

10.  A Structured-based Model for the Decreased Activity of Ala222Val and Glu429Ala Methylenetetrahydrofolate Reductase (MTHFR) Mutants.

Authors:  Khuram Shahzad; Abdul Hai; Asifa Ahmed; Nadeem Kizilbash; Jamal Alruwaili
Journal:  Bioinformation       Date:  2013-11-11
View more
  5 in total

1.  Association of ACE polymorphism and diabetic nephropathy susceptibility.

Authors:  Hongbo Ma; Che Yu; Rong Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization.

Authors:  Liwan Fu; Ya-Nan Li; Dongmei Luo; Shufang Deng; Baihui Wu; Yue-Qing Hu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

3.  Polymorphism of Interleukin 1B May Modulate the Risk of Ischemic Stroke in Polish Patients.

Authors:  Iwona Gorący; Mariusz Kaczmarczyk; Andrzej Ciechanowicz; Klaudyna Lewandowska; Paweł Jakubiszyn; Oksana Bodnar; Bartosz Kopijek; Andrzej Brodkiewicz; Lech Cyryłowski
Journal:  Medicina (Kaunas)       Date:  2019-09-02       Impact factor: 2.430

Review 4.  Association Between MTHFR Polymorphisms and the Risk of Essential Hypertension: An Updated Meta-analysis.

Authors:  Hao Meng; Shaoyan Huang; Yali Yang; Xiaofeng He; Liping Fei; Yuping Xing
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

5.  Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study.

Authors:  Wen-Xing Li; Wen-Wen Lv; Shao-Xing Dai; Ming-Luo Pan; Jing-Fei Huang
Journal:  Lipids Health Dis       Date:  2015-09-04       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.